Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epidermal cell renewal is the lifelong process by which the epidermis, the skin’s outermost layer, maintains itself through cycles of stem cell division, differentiation, and eventual shedding of terminally differentiated keratinocytes. Stem cells in the basal layer divide to produce transit-amplifying cells, which progressively differentiate as they migrate toward the surface, ultimately forming the protective barrier of dead, keratinized squames that are routinely shed and replaced. This process is regulated by multiple signaling pathways, including Wnt, Hedgehog, Notch, BMP, EGF, and integrins. Disruption of renewal rates or signaling fidelity can result in various skin diseases, impaired healing, or tumorigenesis. It is not a single molecule or therapeutic target, but rather a critical, regulated biological process essential for skin integrity and function.
Stimulating keratinocyte proliferation and turnover (e.g., retinoids promote basal cell proliferation) Modulating differentiation signals (e.g., via Wnt, Hedgehog, Notch, EGF/BMP pathways) Modifying inflammation or anti-proliferative effects (e.g., corticosteroids)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epidermal cell renewal.